Source: Business Wire

Press Release: Glaukos : Glaukos Technologies Featured in Presentations at 2018 American Academy of Ophthalmology Conference

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to transform the treatment of glaucoma, announced today that its products will be featured in various presentations at the American Academy of Ophthalmology (AAO) Annual Meeting on October 27-30, 2018 at McCormick Place in Chicago, IL. Glaukos

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Thomas W Burns's photo - President & CEO of Glaukos

President & CEO

Thomas W Burns

CEO Approval Rating


Glaukos is an ophthalmic medical device firm that creates micro invasive glaucoma surgery options for patients. Read more